Global Biologics (Biosimilar) Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Biologics (Biosimilar) market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Biologics (Biosimilar) market are covered in Chapter 9:
Sanofi
Roche
Sandoz
Biotech Pharma
Lilly
Gelgen Biopharma
Johnson & Johnson
Changchun High tech
Mylan
Merck
Hospira
Teva
Novo Nordisk
3sbio
Amgen
Pfizer
Novartis
CP Guojian Pharmacy
AbbVie
In Chapter 5 and Chapter 7.3, based on types, the Biologics (Biosimilar) market from 2017 to 2027 is primarily split into:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
In Chapter 6 and Chapter 7.4, based on applications, the Biologics (Biosimilar) market from 2017 to 2027 covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biologics (Biosimilar) market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biologics (Biosimilar) Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 BIOLOGICS (BIOSIMILAR) MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics (Biosimilar) Market
1.2 Biologics (Biosimilar) Market Segment by Type
1.2.1 Global Biologics (Biosimilar) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biologics (Biosimilar) Market Segment by Application
1.3.1 Biologics (Biosimilar) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biologics (Biosimilar) Market, Region Wise (2017-2027)
1.4.1 Global Biologics (Biosimilar) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.3 Europe Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.4 China Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.5 Japan Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.6 India Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.8 Latin America Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biologics (Biosimilar) (2017-2027)
1.5.1 Global Biologics (Biosimilar) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Biologics (Biosimilar) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biologics (Biosimilar) Market
2 INDUSTRY OUTLOOK
2.1 Biologics (Biosimilar) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Biologics (Biosimilar) Market Drivers Analysis
2.4 Biologics (Biosimilar) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biologics (Biosimilar) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Biologics (Biosimilar) Industry Development
3 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET LANDSCAPE BY PLAYER
3.1 Global Biologics (Biosimilar) Sales Volume and Share by Player (2017-2022)
3.2 Global Biologics (Biosimilar) Revenue and Market Share by Player (2017-2022)
3.3 Global Biologics (Biosimilar) Average Price by Player (2017-2022)
3.4 Global Biologics (Biosimilar) Gross Margin by Player (2017-2022)
3.5 Biologics (Biosimilar) Market Competitive Situation and Trends
3.5.1 Biologics (Biosimilar) Market Concentration Rate
3.5.2 Biologics (Biosimilar) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL BIOLOGICS (BIOSIMILAR) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Biologics (Biosimilar) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biologics (Biosimilar) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Biologics (Biosimilar) Market Under COVID-19
4.5 Europe Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Biologics (Biosimilar) Market Under COVID-19
4.6 China Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Biologics (Biosimilar) Market Under COVID-19
4.7 Japan Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Biologics (Biosimilar) Market Under COVID-19
4.8 India Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Biologics (Biosimilar) Market Under COVID-19
4.9 Southeast Asia Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Biologics (Biosimilar) Market Under COVID-19
4.10 Latin America Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Biologics (Biosimilar) Market Under COVID-19
4.11 Middle East and Africa Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Biologics (Biosimilar) Market Under COVID-19
5 GLOBAL BIOLOGICS (BIOSIMILAR) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Biologics (Biosimilar) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biologics (Biosimilar) Revenue and Market Share by Type (2017-2022)
5.3 Global Biologics (Biosimilar) Price by Type (2017-2022)
5.4 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
5.4.2 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
6 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS BY APPLICATION
6.1 Global Biologics (Biosimilar) Consumption and Market Share by Application (2017-2022)
6.2 Global Biologics (Biosimilar) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biologics (Biosimilar) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biologics (Biosimilar) Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global Biologics (Biosimilar) Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.3 Global Biologics (Biosimilar) Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
6.3.4 Global Biologics (Biosimilar) Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
6.3.5 Global Biologics (Biosimilar) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET FORECAST (2022-2027)
7.1 Global Biologics (Biosimilar) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Biologics (Biosimilar) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Biologics (Biosimilar) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Biologics (Biosimilar) Price and Trend Forecast (2022-2027)
7.2 Global Biologics (Biosimilar) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biologics (Biosimilar) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
7.3.2 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
7.4 Global Biologics (Biosimilar) Consumption Forecast by Application (2022-2027)
7.4.1 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Blood Disorders(2022-2027)
7.4.3 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Growth Hormonal Deficiency(2022-2027)
7.4.4 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Chronic and Autoimmune Disorders(2022-2027)
7.4.5 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Biologics (Biosimilar) Market Forecast Under COVID-19
8 BIOLOGICS (BIOSIMILAR) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Biologics (Biosimilar) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biologics (Biosimilar) Analysis
8.6 Major Downstream Buyers of Biologics (Biosimilar) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biologics (Biosimilar) Industry
9 PLAYERS PROFILES
9.1 Sanofi
9.1.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.1.3 Sanofi Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Roche
9.2.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.2.3 Roche Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Sandoz
9.3.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.3.3 Sandoz Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Biotech Pharma
9.4.1 Biotech Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.4.3 Biotech Pharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Lilly
9.5.1 Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.5.3 Lilly Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Gelgen Biopharma
9.6.1 Gelgen Biopharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.6.3 Gelgen Biopharma Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Changchun High tech
9.8.1 Changchun High tech Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.8.3 Changchun High tech Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Mylan
9.9.1 Mylan Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.9.3 Mylan Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck
9.10.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.10.3 Merck Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Hospira
9.11.1 Hospira Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.11.3 Hospira Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Teva
9.12.1 Teva Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.12.3 Teva Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novo Nordisk
9.13.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.13.3 Novo Nordisk Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 3sbio
9.14.1 3sbio Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.14.3 3sbio Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Amgen
9.15.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.15.3 Amgen Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Pfizer
9.16.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.16.3 Pfizer Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Novartis
9.17.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.17.3 Novartis Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 CP Guojian Pharmacy
9.18.1 CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.18.3 CP Guojian Pharmacy Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AbbVie
9.19.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.19.3 AbbVie Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Biologics (Biosimilar) Market
1.2 Biologics (Biosimilar) Market Segment by Type
1.2.1 Global Biologics (Biosimilar) Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biologics (Biosimilar) Market Segment by Application
1.3.1 Biologics (Biosimilar) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biologics (Biosimilar) Market, Region Wise (2017-2027)
1.4.1 Global Biologics (Biosimilar) Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.3 Europe Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.4 China Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.5 Japan Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.6 India Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.8 Latin America Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Biologics (Biosimilar) Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biologics (Biosimilar) (2017-2027)
1.5.1 Global Biologics (Biosimilar) Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Biologics (Biosimilar) Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biologics (Biosimilar) Market
2 INDUSTRY OUTLOOK
2.1 Biologics (Biosimilar) Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Biologics (Biosimilar) Market Drivers Analysis
2.4 Biologics (Biosimilar) Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biologics (Biosimilar) Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Biologics (Biosimilar) Industry Development
3 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET LANDSCAPE BY PLAYER
3.1 Global Biologics (Biosimilar) Sales Volume and Share by Player (2017-2022)
3.2 Global Biologics (Biosimilar) Revenue and Market Share by Player (2017-2022)
3.3 Global Biologics (Biosimilar) Average Price by Player (2017-2022)
3.4 Global Biologics (Biosimilar) Gross Margin by Player (2017-2022)
3.5 Biologics (Biosimilar) Market Competitive Situation and Trends
3.5.1 Biologics (Biosimilar) Market Concentration Rate
3.5.2 Biologics (Biosimilar) Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL BIOLOGICS (BIOSIMILAR) SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Biologics (Biosimilar) Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biologics (Biosimilar) Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Biologics (Biosimilar) Market Under COVID-19
4.5 Europe Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Biologics (Biosimilar) Market Under COVID-19
4.6 China Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Biologics (Biosimilar) Market Under COVID-19
4.7 Japan Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Biologics (Biosimilar) Market Under COVID-19
4.8 India Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Biologics (Biosimilar) Market Under COVID-19
4.9 Southeast Asia Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Biologics (Biosimilar) Market Under COVID-19
4.10 Latin America Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Biologics (Biosimilar) Market Under COVID-19
4.11 Middle East and Africa Biologics (Biosimilar) Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Biologics (Biosimilar) Market Under COVID-19
5 GLOBAL BIOLOGICS (BIOSIMILAR) SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Biologics (Biosimilar) Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biologics (Biosimilar) Revenue and Market Share by Type (2017-2022)
5.3 Global Biologics (Biosimilar) Price by Type (2017-2022)
5.4 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
5.4.2 Global Biologics (Biosimilar) Sales Volume, Revenue and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
6 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET ANALYSIS BY APPLICATION
6.1 Global Biologics (Biosimilar) Consumption and Market Share by Application (2017-2022)
6.2 Global Biologics (Biosimilar) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biologics (Biosimilar) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biologics (Biosimilar) Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global Biologics (Biosimilar) Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.3 Global Biologics (Biosimilar) Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
6.3.4 Global Biologics (Biosimilar) Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
6.3.5 Global Biologics (Biosimilar) Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL BIOLOGICS (BIOSIMILAR) MARKET FORECAST (2022-2027)
7.1 Global Biologics (Biosimilar) Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Biologics (Biosimilar) Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Biologics (Biosimilar) Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Biologics (Biosimilar) Price and Trend Forecast (2022-2027)
7.2 Global Biologics (Biosimilar) Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Biologics (Biosimilar) Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biologics (Biosimilar) Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
7.3.2 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
7.4 Global Biologics (Biosimilar) Consumption Forecast by Application (2022-2027)
7.4.1 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Oncology(2022-2027)
7.4.2 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Blood Disorders(2022-2027)
7.4.3 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Growth Hormonal Deficiency(2022-2027)
7.4.4 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Chronic and Autoimmune Disorders(2022-2027)
7.4.5 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Others(2022-2027)
7.5 Biologics (Biosimilar) Market Forecast Under COVID-19
8 BIOLOGICS (BIOSIMILAR) MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Biologics (Biosimilar) Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biologics (Biosimilar) Analysis
8.6 Major Downstream Buyers of Biologics (Biosimilar) Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biologics (Biosimilar) Industry
9 PLAYERS PROFILES
9.1 Sanofi
9.1.1 Sanofi Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.1.3 Sanofi Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Roche
9.2.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.2.3 Roche Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Sandoz
9.3.1 Sandoz Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.3.3 Sandoz Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Biotech Pharma
9.4.1 Biotech Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.4.3 Biotech Pharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Lilly
9.5.1 Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.5.3 Lilly Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Gelgen Biopharma
9.6.1 Gelgen Biopharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.6.3 Gelgen Biopharma Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Johnson & Johnson
9.7.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.7.3 Johnson & Johnson Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Changchun High tech
9.8.1 Changchun High tech Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.8.3 Changchun High tech Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Mylan
9.9.1 Mylan Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.9.3 Mylan Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Merck
9.10.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.10.3 Merck Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Hospira
9.11.1 Hospira Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.11.3 Hospira Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Teva
9.12.1 Teva Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.12.3 Teva Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novo Nordisk
9.13.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.13.3 Novo Nordisk Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 3sbio
9.14.1 3sbio Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.14.3 3sbio Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Amgen
9.15.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.15.3 Amgen Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Pfizer
9.16.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.16.3 Pfizer Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Novartis
9.17.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.17.3 Novartis Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 CP Guojian Pharmacy
9.18.1 CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.18.3 CP Guojian Pharmacy Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 AbbVie
9.19.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Biologics (Biosimilar) Product Profiles, Application and Specification
9.19.3 AbbVie Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Biologics (Biosimilar) Product Picture
Table Global Biologics (Biosimilar) Market Sales Volume and CAGR (%) Comparison by Type
Table Biologics (Biosimilar) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Biologics (Biosimilar) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Biologics (Biosimilar) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biologics (Biosimilar) Industry Development
Table Global Biologics (Biosimilar) Sales Volume by Player (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Share by Player (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Share by Player in 2021
Table Biologics (Biosimilar) Revenue (Million USD) by Player (2017-2022)
Table Biologics (Biosimilar) Revenue Market Share by Player (2017-2022)
Table Biologics (Biosimilar) Price by Player (2017-2022)
Table Biologics (Biosimilar) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Biologics (Biosimilar) Sales Volume, Region Wise (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise in 2021
Table Global Biologics (Biosimilar) Revenue (Million USD), Region Wise (2017-2022)
Table Global Biologics (Biosimilar) Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share, Region Wise in 2021
Table Global Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume by Type (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Market Share by Type (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share by Type in 2021
Table Global Biologics (Biosimilar) Revenue (Million USD) by Type (2017-2022)
Table Global Biologics (Biosimilar) Revenue Market Share by Type (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share by Type in 2021
Table Biologics (Biosimilar) Price by Type (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
Table Global Biologics (Biosimilar) Consumption by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Market Share by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Revenue Market Share by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Oncology (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Blood Disorders (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Others (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Biologics (Biosimilar) Price and Trend Forecast (2022-2027)
Figure USA Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Biologics (Biosimilar) Market Sales Volume Forecast, by Type
Table Global Biologics (Biosimilar) Sales Volume Market Share Forecast, by Type
Table Global Biologics (Biosimilar) Market Revenue (Million USD) Forecast, by Type
Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Type
Table Global Biologics (Biosimilar) Price Forecast, by Type
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
Table Global Biologics (Biosimilar) Market Consumption Forecast, by Application
Table Global Biologics (Biosimilar) Consumption Market Share Forecast, by Application
Table Global Biologics (Biosimilar) Market Revenue (Million USD) Forecast, by Application
Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Application
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Blood Disorders (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Growth Hormonal Deficiency (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Chronic and Autoimmune Disorders (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Biologics (Biosimilar) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sanofi Profile
Table Sanofi Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table Sandoz Profile
Table Sandoz Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Biotech Pharma Profile
Table Biotech Pharma Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biotech Pharma Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Biotech Pharma Revenue (Million USD) Market Share 2017-2022
Table Lilly Profile
Table Lilly Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lilly Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Lilly Revenue (Million USD) Market Share 2017-2022
Table Gelgen Biopharma Profile
Table Gelgen Biopharma Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gelgen Biopharma Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Gelgen Biopharma Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Changchun High tech Profile
Table Changchun High tech Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Changchun High tech Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Changchun High tech Revenue (Million USD) Market Share 2017-2022
Table Mylan Profile
Table Mylan Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Mylan Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Hospira Profile
Table Hospira Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hospira Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Hospira Revenue (Million USD) Market Share 2017-2022
Table Teva Profile
Table Teva Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Teva Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table 3sbio Profile
Table 3sbio Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3sbio Biologics (Biosimilar) Sales Volume and Growth Rate
Figure 3sbio Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table CP Guojian Pharmacy Profile
Table CP Guojian Pharmacy Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CP Guojian Pharmacy Biologics (Biosimilar) Sales Volume and Growth Rate
Figure CP Guojian Pharmacy Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Biologics (Biosimilar) Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Figure Biologics (Biosimilar) Product Picture
Table Global Biologics (Biosimilar) Market Sales Volume and CAGR (%) Comparison by Type
Table Biologics (Biosimilar) Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Biologics (Biosimilar) Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Biologics (Biosimilar) Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biologics (Biosimilar) Industry Development
Table Global Biologics (Biosimilar) Sales Volume by Player (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Share by Player (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Share by Player in 2021
Table Biologics (Biosimilar) Revenue (Million USD) by Player (2017-2022)
Table Biologics (Biosimilar) Revenue Market Share by Player (2017-2022)
Table Biologics (Biosimilar) Price by Player (2017-2022)
Table Biologics (Biosimilar) Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Biologics (Biosimilar) Sales Volume, Region Wise (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share, Region Wise in 2021
Table Global Biologics (Biosimilar) Revenue (Million USD), Region Wise (2017-2022)
Table Global Biologics (Biosimilar) Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share, Region Wise in 2021
Table Global Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume by Type (2017-2022)
Table Global Biologics (Biosimilar) Sales Volume Market Share by Type (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume Market Share by Type in 2021
Table Global Biologics (Biosimilar) Revenue (Million USD) by Type (2017-2022)
Table Global Biologics (Biosimilar) Revenue Market Share by Type (2017-2022)
Figure Global Biologics (Biosimilar) Revenue Market Share by Type in 2021
Table Biologics (Biosimilar) Price by Type (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
Table Global Biologics (Biosimilar) Consumption by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Market Share by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption Revenue Market Share by Application (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Oncology (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Blood Disorders (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
Table Global Biologics (Biosimilar) Consumption and Growth Rate of Others (2017-2022)
Figure Global Biologics (Biosimilar) Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Biologics (Biosimilar) Price and Trend Forecast (2022-2027)
Figure USA Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biologics (Biosimilar) Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Biologics (Biosimilar) Market Sales Volume Forecast, by Type
Table Global Biologics (Biosimilar) Sales Volume Market Share Forecast, by Type
Table Global Biologics (Biosimilar) Market Revenue (Million USD) Forecast, by Type
Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Type
Table Global Biologics (Biosimilar) Price Forecast, by Type
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
Figure Global Biologics (Biosimilar) Revenue (Million USD) and Growth Rate of Recombinant Glycosylated Proteins (2022-2027)
Table Global Biologics (Biosimilar) Market Consumption Forecast, by Application
Table Global Biologics (Biosimilar) Consumption Market Share Forecast, by Application
Table Global Biologics (Biosimilar) Market Revenue (Million USD) Forecast, by Application
Table Global Biologics (Biosimilar) Revenue Market Share Forecast, by Application
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Blood Disorders (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Growth Hormonal Deficiency (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Chronic and Autoimmune Disorders (2022-2027)
Figure Global Biologics (Biosimilar) Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Biologics (Biosimilar) Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sanofi Profile
Table Sanofi Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Sanofi Revenue (Million USD) Market Share 2017-2022
Table Roche Profile
Table Roche Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Roche Revenue (Million USD) Market Share 2017-2022
Table Sandoz Profile
Table Sandoz Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sandoz Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Sandoz Revenue (Million USD) Market Share 2017-2022
Table Biotech Pharma Profile
Table Biotech Pharma Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biotech Pharma Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Biotech Pharma Revenue (Million USD) Market Share 2017-2022
Table Lilly Profile
Table Lilly Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lilly Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Lilly Revenue (Million USD) Market Share 2017-2022
Table Gelgen Biopharma Profile
Table Gelgen Biopharma Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Gelgen Biopharma Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Gelgen Biopharma Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Changchun High tech Profile
Table Changchun High tech Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Changchun High tech Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Changchun High tech Revenue (Million USD) Market Share 2017-2022
Table Mylan Profile
Table Mylan Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mylan Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Mylan Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table Hospira Profile
Table Hospira Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hospira Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Hospira Revenue (Million USD) Market Share 2017-2022
Table Teva Profile
Table Teva Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Teva Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Teva Revenue (Million USD) Market Share 2017-2022
Table Novo Nordisk Profile
Table Novo Nordisk Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novo Nordisk Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Novo Nordisk Revenue (Million USD) Market Share 2017-2022
Table 3sbio Profile
Table 3sbio Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3sbio Biologics (Biosimilar) Sales Volume and Growth Rate
Figure 3sbio Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Biologics (Biosimilar) Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table CP Guojian Pharmacy Profile
Table CP Guojian Pharmacy Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CP Guojian Pharmacy Biologics (Biosimilar) Sales Volume and Growth Rate
Figure CP Guojian Pharmacy Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Biologics (Biosimilar) Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Biologics (Biosimilar) Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
